WKL Wolters Kluwer NV

Sentri7 from Wolters Kluwer Earns Category Leader Designation for Clinical Decision Support-Surveillance in the 2017 Best in KLAS Report

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that its Sentri7® solution has received the 2017 Category Leader award for Clinical Decision Support-Surveillance in the 2017 Best in KLAS: Software & Services report. Having captured the Category Leader designation in two previous Best in KLAS reports, the clinical surveillance and decision support platform was awarded top honors for: general satisfaction; functionality and upgrades; and sales and contracting.

Utilizing algorithms to prevent bias, KLAS partners with healthcare providers to provide insight into the quality of healthcare technology solutions. Based on the aggregated feedback of thousands of healthcare professionals and clinicians, the Best in KLAS annual report recognizes the best-performing healthcare IT vendors in more than 100 market segments to ultimately improve vendor performance and guide healthcare provider buying decisions.

Sentri7 drives continuous improvement by leveraging EMR investments to empower clinicians to operate smarter and more efficiently. An interoperable SaaS platform, the HIPAA-compliant clinical decision support surveillance solution provides real-time aggregation of patient data to automate tracking, identification and reporting of patient issues to enable proactive governance and management of critical clinical initiatives such as Antimicrobial Stewardship. Sentri7 clinical content is created and maintained by clinicians and put through a rigorous editorial process that synthesizes the most up-to-date medical information into accurate, trusted, evidence-based alerts and care recommendations designed to achieve important clinical outcomes.

“Hospitals and healthcare organizations are increasingly turning towards clinical surveillance solutions to comply with federal and state regulations, as well as transition to value-based care,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “It is a great honor to have Sentri7 once again recognized by our customers through KLAS as an impactful intervention that aids in providing optimal care.”

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

"2017 Best in KLAS: Software & Services," January 2017. © 2017 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com

EN
02/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details February 27 – March 4, 2026

Share Buyback Transaction Details February 27 – March 4, 2026 PRESS RELEASE                                         Share Buyback Transaction Details February 27 – March 4, 2026 Alphen aan den Rijn – March 5, 2026 - Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 80,106 of its own ordinary shares in the period from February 27, 2026, up to and including March 4, 2026, for €5.5 million and at an average share price of €68.11. Included is a block trade of 61,336 ordinary shares for €4.0 mill...

Guy Sips ... (+10)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update March 2026: Removing Aedifica – Adding Pr...

The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...

 PRESS RELEASE

Wolters Kluwer recognized as one of America’s Best Large Employers for...

Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year PRESS RELEASE Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year Recognition highlights Wolters Kluwer’s strength in top talent and engineering capabilities critical to delivering AI‑powered solutions for customers Alphen aan den Rijn — March 3, 2026 — , global leader in professional information solutions, software, and services, has once again been named among , marking the sixth consecutive year the company has earned a place on the prestigiou...

Wolters Kluwers: 2 directors

Three Directors at Wolters Kluwers bought/sold after exercising options/maiden bought 5,521 shares at between 64.120EUR and 64.790EUR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...

 PRESS RELEASE

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwe...

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer PRESS RELEASE Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer New CEO prioritizes AI investment, partnerships, and go-to-market Alphen aan den Rijn — February 27, 2026 — , a global leader in information solutions, software and services, announced that has officially assumed the role of Chief Executive Officer, succeeding Nancy McKinstry. Caywood brings a strong track record of transforming and growing businesses at Wolters Kluwer through investment in innovation, portfolio management, and c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch